Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001775:Blood Circulation; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002219:Carbamates; D002986:Clinical Trials as Topic; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010991:Plethysmography; D011725:Pyridines / Q000627:therapeutic use*
D002219:Carbamates; D010919:Placebos; D011725:Pyridines; D005954:Glucosephosphate Dehydrogenase; D001920:Bradykinin